Axa S.A. Silence Therapeutics PLC Transaction History

Axa S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$4.61 - $7.44 $2.11 Million - $3.41 Million	-457,792 Reduced 88.65%	58,624 $322,000
Q1 2023 May 15, 2023	SELL	$6.2 - $15.61 $776,550 - $1.96 Million	-125,250 Reduced 19.52%	516,416 $3.2 Million
Q2 2022 Feb 14, 2023	SELL	$7.99 - $19.5 $159,800 - $390,000	-20,000 Reduced 3.02%	641,666 $7.6 Million
Q2 2022 Aug 15, 2022	SELL	$7.99 - $19.5 $159,800 - $390,000	-20,000 Reduced 3.02%	641,666 $7.6 Million
Q1 2022 Feb 14, 2023	BUY	$16.5 - $23.89 $330,000 - $477,800	20,000 Added 3.12%	661,666 $12.6 Million
Q4 2021 Feb 14, 2022	BUY	$20.61 - $25.71 $13.6 Million - $17 Million	661,666 New	661,666 $15.8 Million

27.1M

Ticker SLN
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,888,400
Market Cap $649M
Description
Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.